NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Helen J. Ross, Chen Hu, Kristin Ann Higgins, Salma K. Jabbour, David E. Kozono, Taofeek Kunle Owonikoko, Benjamin Movsas, Timothy Solberg, Canhua Xiao, Terence Marques Williams, James William Welsh, Jeffry Simko, Xiaofei F. Wang, Nisha Anjali Mohindra, Charles Hsu, Tom Stinchcombe, Jeffrey Bradley
Institutions: Johns Hopkins University, Johns Hopkins Medicine, Winship Cancer Institute, Rutgers Cancer Institute, Dana-Farber Cancer Institute, Henry Ford Health, University of Pennsylvania, Emory University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, Duke University, Duke Cancer Institute, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Arizona
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3030062661